Asperger Syndrome - Drug therapy
Research News and Information

Monday, November 23, 2009

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

30 May 2009 OBJECTIVE: The aim of this study was to determine the effectiveness and tolerability of aripiprazole for irritability in pervasive developmental disorder not otherwise specified (PDD-NOS) and Asperger's disorder. METHOD: This is a 14-week, ... Read more...

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

30 May 2009 CONTEXT: Selective serotonin reuptake inhibitors are widely prescribed for children with autism spectrum disorders. OBJECTIVES: To determine the efficacy and safety of citalopram hydrobromide therapy for repetitive behavior in children with autism ... Read more...

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders.

10 May 2009 Medication use was examined in 286 adolescents and adults with ASD over a 4.5 year period. A total of 70% were taking a psychotropic or non-psychotropic medication at the beginning of the study. Both the number of psychotropic and non-psychotropic ... Read more...

Latest indexed articles for 'Asperger Syndrome - Drug therapy'

These are the very latest articles for this heading:

• Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. 30 May 2009
• Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. 30 May 2009
• [Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone] 25 May 2009
• A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. 10 May 2009
• High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder. 30 Mar 2009
• Paliperidone in an adult patient with Asperger syndrome: case report. 21 Mar 2009
• Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. 26 Aug 2008
• Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. 28 Feb 2008
• [New drug therapy of adult attention deficit hyperactivity disorder--evaluation of efficacy of milnacipran] 30 Dec 2007
• [Cerebral physiopathology and treatment of Asperger disorder] 30 Dec 2007
• Effect of propranolol on verbal problem solving in autism spectrum disorder. 30 Dec 2007
• Pharmacological treatment options for autism spectrum disorders in children and adolescents. 30 Dec 2007
• Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. Aug 2007
• Parent-assisted friendship training for children with autism spectrum disorders: effects of psychotropic medication. 30 Mar 2007
• [Pharmacologic treatment of Asperger syndrome] 27 Feb 2007
• Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania. 27 Feb 2007
• Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. 29 Sep 2006
• A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. 29 Sep 2006
• Oxytocin increases retention of social cognition in autism. 12 Aug 2006
• An open trial of olanzapine in children and adolescents with Asperger Disorder. 30 Jan 2006

See a longer list of these articles.

Technical information about 'Asperger Syndrome'

Definition: A childhood disorder predominately affecting boys and similar to autism (AUTISTIC DISORDER). It is characterized by severe, sustained, clinically significant impairment of social interaction, and restricted repetitive and stereotyped patterns of behavior. In contrast to autism, there are no clinically significant delays in language or cognitive development. (From DSM-IV)

Descriptor UI: D020817

Alternative terms: Asperger Syndrome; Asperger's Syndrome; Aspergers Syndrome; Asperger's Disorder; Asperger Disorder; Aspergers Disorder;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;

Tree Number: F03.550.325.100;

History Note: 2000